Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00560794What this trial is testingPhase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic Leukemia Amgen Research (Munich) GmbH 21
Testing effectiveness (Phase 2)Study completedNCT01266083What this trial is testingWT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia Sellas Life Sciences Group 22
Not applicableStudy completedNCT04357041What this trial is testingCOVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-beingWho this might be right forALL, Adult Clinical Nutrition Research Center, Illinois Institute of Technology 440
Not applicableUnknownNCT05973162What this trial is testingEffects of Virtual Reality in Pediatric Burn PatientsWho this might be right forBurns ElbowsPediatric ALL Riphah International University 30
Not applicableStudy completedNCT03545659What this trial is testingChildhood Acute Lymphoblastic Leukaemia: Follow-UpWho this might be right forPrecursor Cell Lymphoblastic Leukemia-LymphomaRecurrence University of Aarhus 277
Not applicableLooking for participantsNCT07203742What this trial is testingThe Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy TreatmentWho this might be right forAcute Lymphoblastic LeukemiaChildhood Acute LeukemiaAcute Myeloblastic Leukaemia Ege University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02514083What this trial is testingA Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLLWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma National Heart, Lung, and Blood Institute (NHLBI) 29
Testing effectiveness (Phase 2)Study completedNCT01814488What this trial is testingA Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute LeukemiaWho this might be right forAcute Leukemia Gruppo Italiano Trapianto di Midollo Osseo 101
Not applicableStudy completedNCT04168788What this trial is testingPharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALLWho this might be right forHepatic Veno-Occlusive DiseaseNephroblastomaAcute Lymphoblastic Leukemia University Hospital, Angers 85
Early research (Phase 1)WithdrawnNCT02914327What this trial is testingSafety and Activity of SNX-5422 Plus Ibrutinib in CLLWho this might be right forCancer Esanex Inc.
Testing effectiveness (Phase 2)Study completedNCT01930162What this trial is testingSafety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood TransplantWho this might be right forSingle Umbilical Cord Blood TransplantationNon-myeloablative ConditioningAcute Lymphocytic Leukemia+4 more Novartis Pharmaceuticals 9
Early research (Phase 1)Study completedNCT01650727What this trial is testingDinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974)Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma Merck Sharp & Dohme LLC 5
Early research (Phase 1)Study completedNCT00005580What this trial is testingBryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Virginia Commonwealth University 54
Testing effectiveness (Phase 2)Study completedNCT00438880What this trial is testingAgatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin LymphomaWho this might be right forAdult Non-Hodgkin LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone Lymphoma+9 more Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT00096096What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06034561What this trial is testingBortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed Remission Instituto do Cancer do Estado de São Paulo 50
Testing effectiveness (Phase 2)Study completedNCT00514696What this trial is testingStudy of the Safety of GCS-100 in Subjects With Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia La Jolla Pharmaceutical Company 12
Testing effectiveness (Phase 2)Study completedNCT00489203What this trial is testingBeclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forHematopoietic/Lymphoid CancerAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+133 more Fred Hutchinson Cancer Center 140
Testing effectiveness (Phase 2)WithdrawnNCT05909527What this trial is testingA Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ LymphomaWho this might be right forT-Cell Acute Lymphocytic Leukemia Guangzhou Bio-gene Technology Co., Ltd